[{"id":"3954a594-f2fe-4b40-b323-eba48a55d9f8","acronym":"","url":"https://clinicaltrials.gov/study/NCT03987568","created_at":"2021-01-18T19:36:28.324Z","updated_at":"2024-07-02T16:35:58.771Z","phase":"","brief_title":"Characterize Tumor Hypoxia by Magnetic Resonance Imaging","source_id_and_acronym":"NCT03987568","lead_sponsor":"Wake Forest University Health Sciences","biomarkers":" FASN • PCNA","pipe":" | ","alterations":" PCNA expression","tags":["FASN • PCNA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PCNA expression"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 07/10/2019","start_date":" 07/10/2019","primary_txt":" Primary completion: 11/15/2021","primary_completion_date":" 11/15/2021","study_txt":" Completion: 11/15/2021","study_completion_date":" 11/15/2021","last_update_posted":"2022-12-21"},{"id":"f104d5a3-8e93-4901-971a-e4e920975ccb","acronym":"","url":"https://clinicaltrials.gov/study/NCT02581917","created_at":"2021-01-18T12:31:18.089Z","updated_at":"2024-07-02T16:36:02.082Z","phase":"","brief_title":"Metabolic Changes in Blood Samples From Patients With Acute Myeloid Leukemia","source_id_and_acronym":"NCT02581917","lead_sponsor":"Wake Forest University Health Sciences","biomarkers":" FASN • PKM","pipe":"","alterations":" ","tags":["FASN • PKM"],"overall_status":"Completed","enrollment":" Enrollment 14","initiation":"Initiation: 04/21/2017","start_date":" 04/21/2017","primary_txt":" Primary completion: 04/01/2021","primary_completion_date":" 04/01/2021","study_txt":" Completion: 04/30/2022","study_completion_date":" 04/30/2022","last_update_posted":"2022-10-20"},{"id":"c6119853-a54c-411a-9b5b-08c79f73833c","acronym":"","url":"https://clinicaltrials.gov/study/NCT02595372","created_at":"2021-01-18T12:35:43.561Z","updated_at":"2024-07-02T16:36:19.483Z","phase":"Phase 2","brief_title":"Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy","source_id_and_acronym":"NCT02595372","lead_sponsor":"Kathy Miller","biomarkers":" HER-2 • FASN","pipe":" | ","alterations":" HER-2 negative","tags":["HER-2 • FASN"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e omeprazole"],"overall_status":"Completed","enrollment":" Enrollment 42","initiation":"Initiation: 11/12/2015","start_date":" 11/12/2015","primary_txt":" Primary completion: 11/21/2019","primary_completion_date":" 11/21/2019","study_txt":" Completion: 03/01/2021","study_completion_date":" 03/01/2021","last_update_posted":"2021-12-15"},{"id":"bed448f1-22e4-48ce-a6f7-2c43952b65df","acronym":"","url":"https://clinicaltrials.gov/study/NCT00908791","created_at":"2021-01-18T03:30:34.481Z","updated_at":"2024-07-02T16:37:01.047Z","phase":"Phase 1","brief_title":"Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue","source_id_and_acronym":"NCT00908791","lead_sponsor":"Dartmouth-Hitchcock Medical Center","biomarkers":" CASP3 • FASN • LPL","pipe":"","alterations":" ","tags":["CASP3 • FASN • LPL"],"overall_status":"Completed","enrollment":" Enrollment 24","initiation":"Initiation: 06/01/2009","start_date":" 06/01/2009","primary_txt":" Primary completion: 03/01/2013","primary_completion_date":" 03/01/2013","study_txt":" Completion: 03/01/2013","study_completion_date":" 03/01/2013","last_update_posted":"2019-04-01"},{"id":"f3f9533d-2d07-48ec-b3dc-0f58595fdf81","acronym":"","url":"https://clinicaltrials.gov/study/NCT00897429","created_at":"2021-01-18T03:26:32.907Z","updated_at":"2024-07-02T16:37:02.654Z","phase":"","brief_title":"Studying Tissue Samples From Patients With Stage II Colon Cancer Treated on Clinical Trial CLB-9581","source_id_and_acronym":"NCT00897429","lead_sponsor":"Alliance for Clinical Trials in Oncology","biomarkers":" BRAF • PIK3CA • MSI • MLH1 • MRE11A • WRN • FASN","pipe":"","alterations":" ","tags":["BRAF • PIK3CA • MSI • MLH1 • MRE11A • WRN • FASN"],"overall_status":"Completed","enrollment":" Enrollment 2059","initiation":"Initiation: 07/01/2007","start_date":" 07/01/2007","primary_txt":" Primary completion: 02/01/2019","primary_completion_date":" 02/01/2019","study_txt":" Completion: 02/01/2019","study_completion_date":" 02/01/2019","last_update_posted":"2019-02-19"},{"id":"cb0d0fa9-8a08-4d06-9ced-b8e8c0234093","acronym":"MRSI+RRP","url":"https://clinicaltrials.gov/study/NCT01780701","created_at":"2021-01-18T07:51:02.976Z","updated_at":"2024-07-02T16:37:23.008Z","phase":"","brief_title":"Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer","source_id_and_acronym":"NCT01780701 - MRSI+RRP","lead_sponsor":"OHSU Knight Cancer Institute","biomarkers":" FASN","pipe":"","alterations":" ","tags":["FASN"],"overall_status":"Completed","enrollment":" Enrollment 66","initiation":"Initiation: 01/01/2013","start_date":" 01/01/2013","primary_txt":" Primary completion: 01/01/2016","primary_completion_date":" 01/01/2016","study_txt":" Completion: 03/01/2017","study_completion_date":" 03/01/2017","last_update_posted":"2017-04-27"},{"id":"e0aff3c8-f404-41c9-bbd1-0c98282944f9","acronym":"","url":"https://clinicaltrials.gov/study/NCT00253643","created_at":"2021-01-18T00:51:35.295Z","updated_at":"2024-07-02T16:37:23.315Z","phase":"","brief_title":"Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer","source_id_and_acronym":"NCT00253643","lead_sponsor":"OHSU Knight Cancer Institute","biomarkers":" FASN","pipe":"","alterations":" ","tags":["FASN"],"overall_status":"Completed","enrollment":" Enrollment 89","initiation":"Initiation: 07/01/2005","start_date":" 07/01/2005","primary_txt":" Primary completion: 09/01/2013","primary_completion_date":" 09/01/2013","study_txt":" Completion: 12/01/2013","study_completion_date":" 12/01/2013","last_update_posted":"2017-04-18"}]